About Ark Biotech
Ark Biotech is a private company based in Westwood, Massachusetts, incorporated in 2021 in Delaware. It has reported $21,680,259 raised in four offerings on Form D since December 2021. Its chief executive is Yosef Quint.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 10, 2024 | May 24, 2024 | $8,180,267of $11.0M target | 8 | $1.0M | EquityRule 506(b) | Form D ↗ |
| Oct 7, 2022 | Oct 24, 2022 | $5,000,000fully sold | 5 | $1.0M | Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Apr 21, 2022 | May 3, 2022 | $5,999,992fully sold | 12 | $499K | EquityRule 506(b) | Form D ↗ |
| Dec 10, 2021 | Dec 23, 2021 | $2,500,000fully sold | 10 | $250K | EquityRule 506(c) | Form D ↗ |
| Total, four offerings | $21,680,259 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Ark Biotech's Form D filed May 24, 2024.
YQ
Yosef Quint
Chief Executive Officer and director
IF
Irving Fain
Director